Analyst firms · Capital One · OTLK

Capital One OTLK price target and rating history

Outlook Therapeutics Inc. (OTLK) · Health Care

Capital One rates Outlook Therapeutics Inc. (OTLK) Overweight with a $5 price target, as of its latest action on Dec 27, 2023. It has published 3 rating actions on OTLK since July 2023, including 1 upgrade and 1 downgrade.

Current rating
Overweight
Price target
$5
Median target, all firms
Too few
Actions on OTLK
3

Capital One price target on OTLK

$5.50$5$4.50202420252026
Capital One price target on OTLK, each point a stated target, July 2023 to December 2023.

Every Capital One rating on OTLK

Questions about Capital One and OTLK

What is Capital One's price target for OTLK?
Capital One's latest stated price target for Outlook Therapeutics Inc. (OTLK) is $5, from its action on Dec 27, 2023.
What is Capital One's rating on OTLK?
Capital One rates OTLK Overweight, a bullish rating, as of Dec 27, 2023.
When did Capital One last change its view on OTLK?
On Dec 27, 2023, Capital One upgrades to Overweight from Equal Weight, price target $5.

More OTLK rating histories

All Capital One ratingsOTLK news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.